Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper
- PMID: 38013608
- DOI: 10.1111/all.15961
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper
Abstract
Proton pump inhibitors (PPIs) are invaluable therapeutic options in a variety of dyspeptic diseases. In addition to their well-known risk profile, PPI consumption is related to food and environmental allergies, dysbiosis, osteoporosis, as well as immediate and delayed hypersensitivity reactions (HSRs). The latter, although a rare event, around 1%-3%, due to the extraordinarily high rate of prescription and consumption of PPIs are related to a substantial risk. In this Position Paper, we provide clinicians with practical evidence-based recommendations for the diagnosis and management of HSRs to PPIs. Furthermore, the unmet needs proposed in the document aim to stimulate more in-depth investigations in the topic.
Keywords: allergy; anaphylaxis; drug hypersensitivity; hypersensitivity reaction; proton pump inhibitors.
© 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
References
REFERENCES
-
- Gibbison B, Sheikh A, McShane P, Haddow C, Soar J. Anaphylaxis admissions to UK critical care units between 2005 and 2009. Anaesthesia. 2012;67:833-839.
-
- Lombardo C, Bonadonna P. Hypersensitivity reactions to proton pump inhibitors. Curr Treat Options Allergy. 2015;2:110-123.
-
- Bonadonna P, Lombardo C, Bortolami O, et al. Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test. J Allergy Clin Immunol. 2012;130:547-549.
-
- Ward RM, Kearns GL. Proton pump inhibitors in pediatrics. Pediatr Drugs. 2013;15:119-131.
-
- Thomson ABR, Sauve MD, Kassam N, Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol. 2010;16:2323-2330.